Texas Yale Capital Corp’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Texas Yale Capital Corp’s Portfolio KLDO Stock Details KLDO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,000	Closed	-$17K	–	488
2022 Q1	$17K	Hold	10,000	–	–	﹤0.01%	465
2021 Q4	$24K	Hold	10,000	–	–	﹤0.01%	469
2021 Q3	$55K	Hold	10,000	–	–	﹤0.01%	459
2021 Q2	$74K	Buy	+10,000	New	+$70.9K	﹤0.01%	462

Other funds holding KLDO

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Texas Yale Capital Corp's KLDO Position: Q2 2022 in Review

Texas Yale Capital Corp sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 10,000 shares — an estimated $17K sold.

Texas Yale Capital Corp first reported a position in KLDO in Q2 2021 and held it in 4 quarters. The position peaked at $74K in Q2 2021. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

Texas Yale Capital Corp reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Texas Yale Capital Corp sold 10,000 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $17K.
Texas Yale Capital Corp first reported a position in Kaleido Biosciences, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
Texas Yale Capital Corp's Kaleido Biosciences, Inc. Common Stock position peaked at $74K in Q2 2021.
3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on Texas Yale Capital Corp's 13F filing for Q2 2022, filed 11 Aug 2022.